EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Sernova Biotherapeutics Inc. (T.SVA) EBIT Margin data is not available.
| Income Statement Financials | |
-- |
|
-11.24M |
|
-- |
|
-- |
|
-- |
|
-10.72M |
|
-- |
|
-11.23M |
|
-11.23M |
|
-11.24M |
|
-11.24M |
|
-11.24M |
|
-11.24M |
|
-10.72M |
|
-10.48M |
|
328.29M |
|
328.29M |
|
-0.04 |
|
-0.04 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
0.55M |
|
-- |
|
-- |
|
-- |
|
18.44M |
|
-17.90M |
|
-17.90M |
|
-17.90M |
|
332.86M |
|
| Cash Flow Statement Financials | |
-7.79M |
|
0.02M |
|
3.67M |
|
4.29M |
|
0.19M |
|
-4.10M |
|
1.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-0.04 |
|
-0.19 |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
-7.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
62.78% |
|
62.78% |
|
-2060.03% |
|
65.51% |
|
-0.08 |
|
-0.02 |
|
-0.02 |
|